World News | FDA OKs Third Antibody Drug for COVID-19 Cases
Get latest articles and stories on World at LatestLY. U.S. health officials have granted emergency authorisation to a third antibody drug to help reduce hospitalisations and deaths due to COVID-19.
Washington, May 27 (AP) U.S. health officials have granted emergency authorisation to a third antibody drug to help reduce hospitalisations and deaths due to COVID-19.
The FDA said Wednesday it authorised the drug from GlaxoSmithKline and Vir Biotechnology for people with mild-to-moderate cases of COVID-19 who face extra risks of severe illness, including seniors and those with underlying health problems.
There has been low demand for two similar drugs already available, due mainly to the logistical hurdles of delivering them and confusion about their availability. U.S. health officials have been trying to raise awareness of the treatments, connecting people who test positive for COVID-19 with information about nearby providers.
The drugs are delivered as a one-time intravenous infusion at a hospital or clinic and should be given within 10 days of the start of symptoms. (AP)
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)